Showing results (111-120 of 900) with videos related to
Sort By:
Pageof 90
The Lancet. Haematology|April 1, 2023
Using immunotherapy and novel trial designs to optimise front-line therapy in adult acute lymphoblastic leukaemia: breaking with the traditions of the pastNicholas J Short, Hagop KantarjianCurrent Oncology Reports|February 17, 2017
Minimal Residual Disease in Acute Lymphoblastic Leukemia: How to Recognize and Treat ItNicholas J Short, Elias JabbourCurrent Oncology Reports|February 10, 2022
Central Nervous System Involvement in Adults with Acute Leukemia: Diagnosis, Prevention, and ManagementShilpa Paul, Nicholas J ShortAmerican Journal of Hematology|September 25, 2024
Measurable residual disease monitoring in AML: Prospects for therapeutic decision-making and new drug developmentNicholas J Short, Richard DillonJAMA Oncology|July 17, 2015
Toward Individualized Therapy in Acute Myeloid Leukemia: A Contemporary ReviewTapan M Kadia, Farhad Ravandi, Jorge Cortes, et al.Archives of Pathology & Laboratory Medicine|June 16, 2025
Technical and Clinical Validity of Assessing Measurable Residual Disease by Multicolor Flow Cytometry in an Unselected Acute Myeloid Leukemia Patient CohortSa A Wang, Shaoying Li, Wei Wang, et al.Leukemia & Lymphoma|August 19, 2025
Mortality and relapse dynamics in AML after three years of complete remissionSamuel Urrutia, Wei-Ying Jen, Koji Sasaki, et al.The Lancet. Haematology|June 30, 2022
Choosing between intensive and less intensive front-line treatment approaches for older patients with newly diagnosed acute myeloid leukaemiaNicholas J Short, Hagop KantarjianAmerican Journal of Hematology|July 24, 2022
Hypomethylating agents for the treatment of myelodysplastic syndromes and acute myeloid leukemia: Past discoveries and future directionsNicholas J Short, Hagop KantarjianTherapeutic Advances in Hematology|October 19, 2023
The history of oral decitabine/cedazuridine and its potential role in acute myeloid leukemiaRobert Briski, Guillermo Garcia-Manero, Hagop Kantarjian, et al.Pageof 90